0 TSX News - December 3, 2024Algoma Steel Group to Participate in the Inaugural B. Riley Securities Energy Convergence ConferenceSAULT STE. MARIE, Ontario, Dec. 03, 2024 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or […]Read More
0 TSX News - December 3, 2024Diversified Royalty Corp. Announces December 2024 Cash DividendVANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is […]Read More
0 TSX News - December 3, 2024Descartes Announces Fiscal 2025 Third Quarter Financial ResultsRecord Revenues as Global Logistics Network Expands WATERLOO, Ontario and ATLANTA, Dec. 03, 2024 (GLOBE NEWSWIRE) — The Descartes Systems […]Read More
0 TSX News - December 3, 2024Colliers announces appointment of John Sullivan to Board of DirectorsTORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) — Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers”) announced that John Sullivan […]Read More
0 TSX News - December 3, 2024Theratechnologies Announces Resumed Production of EGRIFTA SV®MONTREAL, Dec. 03, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]Read More
0 TSX News - December 3, 2024Cartier Intersects High Grade Values on Globex’s Nordeau West Royalty ClaimsROUYN-NORANDA, Quebec, Dec. 03, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]Read More
0 TSX News - December 3, 2024Fairfax India to Acquire an Additional 10% Interest in Bangalore International Airport LimitedNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this […]Read More
0 TSX News - December 3, 2024Orezone Publishes 2023 Sustainability ReportVANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) […]Read More
0 TSX News - December 3, 2024Aptose Signs CRADA with NCI to Develop Tuspetinib for AML and MDS in Newly Launched MyeloMATCH Precision Medicine TrialsTuspetinib selected for a prestigious national clinical research program for ability to target broad spectrum of AML and MDS populations […]Read More
0 TSX News - December 3, 2024Troilus Announces Key Leadership Appointment and Provides Operational UpdateMONTREAL, Dec. 03, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) […]Read More